EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
The 78th World Health Assembly agrees to extend the Global Action Plan on the Public Health Response to Dementia
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
Advocating around the world in 31 Days: A round-up of global action in March 2024
From symposiums and conferences to high-level meetings and webinars, ADI delegates around the world have taken part in dynamic global efforts to improve the lives of those living with dementia and carers throughout the month of March.
Celebrating Global Excellence: Wicking Dementia Centre Receives ADI Accreditation
The Wicking Dementia Centre celebrates its achievement of gaining ADI Accreditation, becoming Australia's first educational provider to attain this award. This is a significant milestone in global dementia education and marks Wicking's dedication to excellence and its commitment to enhancing care standards worldwide.
Royals set to join ADI’s 36th International Conference
ADI is pleased to welcome both Her Majesty The Queen Sofía of Spain and Her Royal Highness Princess Muna Al Hussein of Jordan to ADI’s 36th International Conference
Expanding Dementia Research in Latin America: ADI at the ReD-Lat Annual Meeting in Buenos Aires
ADI’s Director of the Americas attends the ReD-Lat Annual Meeting in Buenos Aires, Argentina with the aim to strengthen the bonds between ADI's members and researchers attending ReD-Lat; fostering collaboration and knowledge exchange to advance the field of dementia research in Latin America and the Caribbean.
ADI attends the WHO Executive Board: A week of advocacy in Europe and beyond
As the global voice on dementia, ADI has embarked on impactful week of advocacy in Europe and beyond. Attending the WHO Executive Board meetings in Geneva, a high level meeting of health ministries at OECD, Paris, and virtually joining the HGPI in Japan. With key members of ADI staff making multiple addresses to international bodies seeking to improve and strengthen policies that relate to dementia.
ADI joins AD-RIDDLE, a new initiative to improve detection, diagnosis and prevention of Alzheimer’s disease
AD-RIDDLE, funded by the Innovative Health Initiative, a European Union public privative partnership, brings together academics, healthcare providers, pharmaceutical companies, regulatory bodies to develop tools and resources for healthcare providers.
Lived experience at the heart of innovation
ADI calls for lived experience to be central to innovation in the field of dementia diagnostics, treatment and care. In her short interview with Novartis, Paola Barbarino highlights key areas which innovators must consider when developing their products and service, from inception, to testing and ultimately bringing them to market; and reminds us not to forget that simple innovative changes can lead to great impact.
Harmony Amid Diversity: ADI Caribbean and Latin American Members Meeting in Puerto Rico
Diego Aguilar, Regional Director for the Americas gives his insights on the recent ADI members meeting for Latin America and the Caribbean, held in San Juan, Puerto Rico in early December 2023.